Parkinsons Articles

New Method Devised to Generate Dopaminergic Neurons

Researchers have devised a new method to generate dopamine-producing neurons from skin cells of Parkinson’s disease patients, a process that could be used to better study the molecular mechanisms of the disease and develop new

https://parkinsonsnewstoday.com/news/new-way-make-dopaminergic-neurons-aid-parkinsons-research/

Parkinsons News Today

Repeated Smell Testing May Help ID Those at Risk for Parkinson’s

People with persistent smell deficits are more likely to develop brain imaging abnormalities suggestive of Parkinson’s disease, or be diagnosed with the disease, than those whose deficits return to normal on a subsequent smell test,

https://parkinsonsnewstoday.com/news/repeated-smell-testing-identify-risk-parkinsons/

Parkinsons News Today

Study: RAGE Protein Plays Key Role in Parkinson’s Neuroinflammation

Scientists have shed new light on the interaction of toxic apha-synuclein clumps — a hallmark of Parkinson’s disease — with microglia, the brain’s immune cells. This interaction was found to be mediated by RAGE, a

https://parkinsonsnewstoday.com/news/rage-protein-may-mediate-neuroinflammation-parkinsons-study/

Parkinsons News Today

Servier Licenses LRRK2 Inhibitor, Phase 1 Trial to Start by Year’s End

Servier is set to launch a Phase 1 clinical trial in healthy volunteers to investigate an LRRK2 inhibitor, developed in collaboration with Oncodesign, as a treatment for Parkinson’s disease. The trial, to start before the end

https://parkinsonsnewstoday.com/news/servier-licenses-lrrk2-inhibitor-phase-1-trial-start-year-end/

Parkinsons News Today